# Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment

> **NCT01257061** · PHASE3 · COMPLETED · sponsor: **EMS** · enrollment: 310 (actual)

## Conditions studied

- Eczema

## Interventions

- **DRUG:** Group 1
- **DRUG:** Group 2

## Key facts

- **NCT ID:** NCT01257061
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-06
- **Primary completion:** 2013-04-30
- **Final completion:** 2013-08-02
- **Target enrollment:** 310 (ACTUAL)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01257061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01257061, "Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01257061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
